Editor's Audio Summary by Edward H. Livingston, MD, Deputy Editor, the Journal of the American Medical Association, for the February 19, 2014 issue
Porsteinsson and colleagues evaluate the efficacy of citalopram for agitation in patients with Alzheimer disease in a randomized controlled trial comprising 186 patients with probable Alzheimer disease and clinically significant agitation from 8 US and Canadian centers, August 2009-January 2013.
In a randomized trial, Morillo and colleagues compared radiofrequency ablation with antiarrhythmic drugs as a first-line therapy in 127 patients with paroxysmal atrial fibrillation and found ablation was associated with a lower rate of recurrent tachyarrhythmias at 2 years, but recurrence was frequent in both groups.
Latham and coauthors report the results from a randomized clinical trial of a home-based exercise program for functional recovery following traditional rehabilitation after hip fracture.
To determine the incidence of clinically significant surgical site infections (CS-SSIs) requiring acute care following ambulatory surgery, Owens and coauthors performed a retrospective analysis of Healthcare Cost and Utilization Projectstate databases for 8 geographically dispersed states.
Wells and coauthors reviewed the literature to assess the etiology and treatment of the 3 phases of venous thromboembolism: acute, long-term, and extended.